VEMIX
Price
$33.35
Change
-$1.09 (-3.16%)
Updated
Oct 10 closing price
Net Assets
138.25B
VEMRX
Price
$110.94
Change
-$3.62 (-3.16%)
Updated
Oct 10 closing price
Net Assets
138.25B
Interact to see
Advertisement

VEMIX vs VEMRX

Header iconVEMIX vs VEMRX Comparison
Open Charts VEMIX vs VEMRXBanner chart's image
Vanguard Emerging Mkts Stock Idx Instl
Price$33.35
Change-$1.09 (-3.16%)
VolumeN/A
Net Assets138.25B
Vanguard Emerging Mkts Stock Idx InsPlus
Price$110.94
Change-$3.62 (-3.16%)
VolumeN/A
Net Assets138.25B
VEMIX vs VEMRX Comparison Chart in %
View a ticker or compare two or three
VS
VEMIX vs. VEMRX commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VEMIX is a Hold and VEMRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMIX (138B) and VEMRX (138B) have equal amount of cash in the bank . VEMRX (2.84) and VEMIX (2.82) have matching dividends . VEMIX was incepted earlier than VEMRX: VEMIX (25 years) vs VEMRX (15 years). VEMIX (0.09) is less costly to investors than VEMRX (0.07). VEMIX (8.00) and VEMRX (8.00) have comparable annual turnover. VEMIX has a lower initial minimum investment than VEMRX: VEMIX (5000000) vs VEMRX (100000000). VEMIX (16.35) and VEMRX (16.35) have marching annual gain over last year. VEMRX (34.28) and VEMIX (34.19) have equivalent 5 years return.
VEMIXVEMRXVEMIX / VEMRX
Total Expense Ratio0.090.07129%
Annual Report Gross Expense Ratio0.090.07129%
Fund Existence25 years15 years-
Gain YTD23.88023.898100%
Front LoadN/AN/A-
Min. Initial Investment50000001000000005%
Min. Initial Investment IRAN/AN/A-
Net Assets138B138B100%
Annual Yield % from dividends2.822.8499%
Returns for 1 year16.3516.35100%
Returns for 3 years61.2761.31100%
Returns for 5 years34.1934.28100%
Returns for 10 years81.4281.67100%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.190.29
+0.97%
Stoke Therapeutics
FORLU11.80-0.01
-0.08%
Four Leaf Acquisition Corp
GNTA3.25-0.05
-1.51%
Genenta Science SpA
KT18.57-0.34
-1.80%
KT Corp.
TMCI5.88-0.15
-2.49%
Treace Medical Concepts